logo
logo

Respiratory Syncytial Virus Therapeutics Market Global Demand, Trends, Growth, Industry Share and Size Expansion to 2027

avatar
Avani Sable
Oct 18, 2021 05:11
img

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019. It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.

For More Questions, Talk with Respiratory Syncytial Virus (RSV) Therapeutics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/respiratory-syncytial-virus-rsv-therapeutics-market-104668

High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical Space

The COVID-19 contagion is expected to drive the global pharmaceutical industry. Enterprises across the world along with governments from several nations are contributing to the development and distribution of the vaccine. However, the scale at which the production is assumed to take place is a major challenge for most of the renowned players. At Fortune Business Insights™, we are providing actionable insights by closely studying multiple aspects of the current scenario. We are also offering firsthand information on various market trends through our comprehensive research reports.

New Product Launches from Key Players Helped Prophylaxis Segment Hold Largest Share In 2019

Based on drug class, the prophylaxis segment led the market with the largest share in 2019. Potential approvals and launch of maternal vaccines by companies including Pfizer and GSK are estimated to help the segment further dominate the market during the forecast timeframe. Based on end-user, the hospital pharmacy segment dominated the global market owing to the high demand for healthcare professionals for the existing treatment and prevention options.

collect
0
avatar
Avani Sable
Oct 18, 2021 05:11
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.